Crocs products are sold in 90 countries. Every day, millions of Crocs shoe lovers around the world enjoy the exceptional form, function, versatility and feel-good qualities of these shoes while at work, school and play.

The TLR-targeted candidates of Idera Pharmaceuticals (Nasdaq: IDRA) are being developed to treat autoimmune and inflammatory diseases, cancer, and for use as vaccine adjuvants. Idera Pharmaceuticals applies its proprietary Toll-like Receptor (TLR) drug discovery platform to create immunomodulatory drug candidates.

Idera Pharmaceuticals Presents Data in Preclinical Models of Lymphoma on IMO-4200, a Dual Agonist of TLRs 7 and 8, at the American Society for Hematology Meeting

INTL, INTL FCStone Inc.

** On its fourth quarter fiscal 2011 results, INTL posted (Unaudited) total operating revenues of $108.1 million dollars, a 64% increase year over year while fiscal 2011 was a record year for the company in both adjusted operating revenues and adjusted net income.